EDGAR Filing Documents for 0001144204-18-051627

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-18-051627

Filing Date

2018-10-01

Accepted

2018-10-01 06:02:13

Documents

Period of Report

2018-10-01

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tv503870_6k.htm	6-K	10616
2	EXHIBIT 99.1	tv503870_ex99-1.htm	EX-99.1	19607
	Complete submission text file	0001144204-18-051627.txt		31408

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 181095753
SIC: 2834 Pharmaceutical Preparations